Advanced Therapies Europe / Agenda / Commercialising Future Therapies
Back

The EU Health Technology Assessment Regulations: Pricing & Reimbursement Opportunities of Novel Therapeutics in Europe

06 Sep 2023
16:45
Stream 2
SPONSORED BY
SKC Beratungsgesellschaft mbH

16:45pm Chair Introduction 

Chairperson: Oresta Piniazhko, Director, HTA Department, State Expert Center, MOH of Ukraine

 

Panel Participants 

  • Paolo Morgese, Head of Public Affairs, Europe, Alliance for Regenerative Medicine 
  • Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics 
  • Lydia Frick, Manager Market Access, SKC Beratungsgesellchaft
  • Åse Rosenqvist, Nordic Business Unit Lead Cell Therapy, Janssen 
  • Miguel Forte, Chief Executive Officer, Kiji Therapeutics, President-Elect, ISCT

 

Speakers

Oresta Piniazhko
Oresta Piniazhko
Director, HTA Department, State Expert Center
MoH of Ukraine
Paolo Morgese
Paolo Morgese
Head of Public Affairs, Europe
Alliance for Regenerative Medicine
Thomas Bols
Thomas Bols
Head of Government Affairs and Patient Advocacy, EMEA
PTC Therapeutics
Lydia Frick
Lydia Frick
Manager Market Access
SKC Beratungsgesellschaft mbH
Miguel Forte
Miguel Forte
Chief Executive Officer, Kiji Therapeutics, President-Elect
ISCT